These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10413381)

  • 1. Transient local changes in right ventricular monophasic action potentials due to ajmaline in a patient with Brugada Syndrome.
    Eckardt L; Kirchhof P; Johna R; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):1010-5. PubMed ID: 10413381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
    Stix G; Bella PD; Carbucicchio C; Schmidinger H
    J Cardiovasc Electrophysiol; 2000 May; 11(5):516-21. PubMed ID: 10826930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST-Elevation Magnitude Correlates With Right Ventricular Outflow Tract Conduction Delay in Type I Brugada ECG.
    Leong KMW; Ng FS; Yao C; Roney C; Taraborrelli P; Linton NWF; Whinnett ZI; Lefroy DC; Davies DW; Boon Lim P; Harding SE; Peters NS; Kanagaratnam P; Varnava AM
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29038102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effect of ajmaline in a patient with Brugada syndrome.
    Sassone B; Saccà S; Donateo M
    Europace; 2006 Apr; 8(4):251-4. PubMed ID: 16627450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
    Eckardt L; Bruns HJ; Paul M; Kirchhof P; Schulze-Bahr E; Wichter T; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):742-9. PubMed ID: 12212690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical ECG changes unmasked by ajmaline in a patient with Brugada syndrome and left bundle branch block.
    Ozin B; Atar I; Altunkeser B; Ertan C; Yildirir A; Müderrisoğlu H
    Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):378-81. PubMed ID: 16029391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome.
    Pinar Bermúdez E; García-Alberola A; Martínez Sánchez J; Sánchez Muñoz JJ; Valdés Chávarri M
    Pacing Clin Electrophysiol; 2000 Mar; 23(3):407-9. PubMed ID: 10750146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report.
    Karaca M; Dinckal MH
    Acta Cardiol; 2006 Aug; 61(4):481-4. PubMed ID: 16970061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of Brugada and Wolff Parkinson White syndromes: A case report and review of the literature.
    Aksan G; Tezcan M; Çevrim Ö; Elitok A; Bilge AK
    Turk Kardiyol Dern Ars; 2018 Oct; 46(6):488-493. PubMed ID: 30204140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dispersion of repolarization time determined by monophasic action potentials in two patients with familial idiopathic ventricular fibrillation.
    Matsuo K; Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
    J Cardiovasc Electrophysiol; 1998 Jan; 9(1):74-83. PubMed ID: 9475580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Provocation of Outflow-Tract Tachycardia in a Patient With Brugada Syndrome.
    Bürkle G; Schäfer H; Marschall C; Brugada P; Ehrlich JR
    Can J Cardiol; 2016 Dec; 32(12):1577.e5-1577.e7. PubMed ID: 27032887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brugada-Brugada syndrome. An atypical case].
    Breuer HW; Breithardt G; Borggrefe M
    Z Kardiol; 1999 Jul; 88(7):467-72. PubMed ID: 10467645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocardial repolarization dispersion in BrS: A novel automatic algorithm for mapping activation recovery interval.
    Latrofa S; Hartwig V; Bachi L; Notarstefano P; Garibaldi S; Panchetti L; Nesti M; Seghetti P; Startari U; Mirizzi G; Morelli MS; Modena M; Mazzanti A; Emdin M; Giannoni A; Rossi A
    J Cardiovasc Electrophysiol; 2024 May; 35(5):965-974. PubMed ID: 38477371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action potential alternans in the right ventricular outflow tract in a patient with asymptomatic Brugada syndrome.
    Kofune M; Watanabe I; Ashino S; Ohkubo K; Okumura Y; Kofune T; Nakai T; Hirayama A
    Circ J; 2009 Mar; 73(3):580-3. PubMed ID: 19075522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch.
    Hoogendijk MG; Potse M; Linnenbank AC; Verkerk AO; den Ruijter HM; van Amersfoorth SC; Klaver EC; Beekman L; Bezzina CR; Postema PG; Tan HL; Reimer AG; van der Wal AC; Ten Harkel AD; Dalinghaus M; Vinet A; Wilde AA; de Bakker JM; Coronel R
    Heart Rhythm; 2010; 7(2):238-48. PubMed ID: 20022821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome.
    Chinushi M; Aizawa Y; Ogawa Y; Shiba M; Takahashi K
    J Electrocardiol; 1997 Apr; 30(2):133-6. PubMed ID: 9141608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.